Omega Therapeutics Inc (OMGA)
0.786
+0.01
(+1.29%)
USD |
NASDAQ |
Nov 22, 16:00
0.765
-0.02
(-2.67%)
After-Hours: 20:00
Omega Therapeutics Enterprise Value: 28.73M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 28.73M |
| November 21, 2024 | 28.17M |
| November 20, 2024 | 28.96M |
| November 19, 2024 | 27.29M |
| November 18, 2024 | 27.58M |
| November 15, 2024 | 31.08M |
| November 14, 2024 | 41.13M |
| November 13, 2024 | 44.45M |
| November 12, 2024 | 48.33M |
| November 11, 2024 | 45.56M |
| November 08, 2024 | 45.56M |
| November 07, 2024 | 46.99M |
| November 06, 2024 | 47.54M |
| November 05, 2024 | 49.19M |
| November 04, 2024 | 42.58M |
| November 01, 2024 | 46.44M |
| October 31, 2024 | 49.19M |
| October 30, 2024 | 55.26M |
| October 29, 2024 | 53.61M |
| October 28, 2024 | 55.26M |
| October 25, 2024 | 61.88M |
| October 24, 2024 | 65.19M |
| October 23, 2024 | 59.12M |
| October 22, 2024 | 61.88M |
| October 21, 2024 | 44.23M |
| Date | Value |
|---|---|
| October 18, 2024 | 43.68M |
| October 17, 2024 | 42.58M |
| October 16, 2024 | 35.11M |
| October 15, 2024 | 34.52M |
| October 14, 2024 | 37.70M |
| October 11, 2024 | 38.16M |
| October 10, 2024 | 39.72M |
| October 09, 2024 | 44.23M |
| October 08, 2024 | 44.23M |
| October 07, 2024 | 44.23M |
| October 04, 2024 | 46.99M |
| October 03, 2024 | 48.09M |
| October 02, 2024 | 45.33M |
| October 01, 2024 | 51.40M |
| September 30, 2024 | 52.50M |
| September 27, 2024 | 43.86M |
| September 26, 2024 | 40.55M |
| September 25, 2024 | 40.55M |
| September 24, 2024 | 43.86M |
| September 23, 2024 | 44.41M |
| September 20, 2024 | 46.62M |
| September 19, 2024 | 49.38M |
| September 18, 2024 | 49.93M |
| September 17, 2024 | 46.07M |
| September 16, 2024 | 44.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-84.74M
Minimum
Jun 01 2022
1.181B
Maximum
Oct 29 2021
211.09M
Average
130.84M
Median
Aug 09 2023
Enterprise Value Benchmarks
| Moderna Inc | 8.953B |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.44M |
| Revenue (Quarterly) | 2.612M |
| Total Expenses (Quarterly) | 19.03M |
| EPS Diluted (Quarterly) | -0.30 |
| Profit Margin (Quarterly) | -629.6% |
| Earnings Yield | -167.9% |
| Normalized Earnings Yield | -167.94 |